Bladder cancer breakthrough? MRI may predict chemo success in days
NCT ID NCT07202845
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a special type of MRI (multiparametric MRI) can predict early on if chemotherapy is working for muscle-invasive bladder cancer. 39 participants will get three MRI scans: before chemo, one day after the first dose, and after finishing chemo. The goal is to see if changes in the MRI can tell doctors whether the tumor is shrinking, helping avoid unnecessary delays and toxicity from ineffective treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Multiparametric Magnetic Resonance Imaging (mpMRI)
- What this could lead to
- If successful, this could allow doctors to quickly tell if chemotherapy is working for bladder cancer patients, enabling them to switch treatments sooner and avoid unnecessary side effects.
- What could go wrong
- This is a small, early study with only 39 participants, so results may not apply to everyone. The MRI technique is still experimental and not yet proven to reliably predict outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIBC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Amr E. Darwish
RECRUITINGAsyut, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.